NFKB1 and Hydrocephalus: These results further our understanding of the pathogenesis of hydrocephalus and may lead to new treatment strategies by inhibiting TLR4‐NF‐κB to modulate inflammation in the hydrocephalic brain, thereby, brain function damage can be mitigated, and even the shunt related hydrocephalus process can be avoided.